Epidermal Growth Factor Receptor modulates the tumorigenic potential of melanoma

Frontiers in Bioscience

Volumn 14, Issue 1, 2009, Pages 159-166

  Diaz, Arlhee ^a   Suarez, Eduardo ^a   Blanco, Rances ^a   Lopez, Armando ^a   Montero, Enrique ^a  

^a CENTER OF MOLECULAR IMMUNOLOGY   (Cuba)

Author keywords

B16F10; Epidermal Growth Factor Receptor; Melanoma; Tumor editing; Tumor growth

Indexed keywords

MUS;

EPIDERMAL GROWTH FACTOR RECEPTOR; PRIMER DNA;

ANIMAL; ARTICLE; C57BL MOUSE; DOWN REGULATION; EXPERIMENTAL MELANOMA; FEMALE; GENETIC TRANSFECTION; GENETICS; HUMAN; IMMUNE DEFICIENCY; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; MOUSE; NUCLEOTIDE SEQUENCE; PATHOLOGY; PHYSIOLOGY; POLYMERASE CHAIN REACTION; TRANSGENE; WESTERN BLOTTING;

ANIMALS; BASE SEQUENCE; BLOTTING, WESTERN; DNA PRIMERS; DOWN-REGULATION; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; POLYMERASE CHAIN REACTION; RECEPTOR, EPIDERMAL GROWTH FACTOR; TRANSFECTION; TRANSGENES;

EID: 63849107215     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/3237     Document Type: Article

References (28)

1. Baselga J.: Why the epidermal growth factor receptor? The rationale for cancer therapy. Oncologist 7 Suppl 4, 2-8(2002) (Pubitemid 34977157)
2. Raymond E., S. Faivre & J. P. Armand: Epidermal growth factor receptor tyrosine kinase as a target for anticancer therapy. Drugs 60 Suppl 1, 15-23; discussion 41-12 (2000)
3. Carpenter G.: Receptors for epidermal growth factor and other polypeptide mitogens. Annu Rev Biochem 56, 881-914(1987). 10.1146/annurev. bi.56.070187.004313
4. Woodburn J. R.: The epidermal growth factor receptor and its inhibition in cancer therapy. Pharmacol Ther 82, 241-250(1999) (Pubitemid 29255919)
5. Hanahan D. & R. A. Weinberg: The hallmarks of cancer. Cell 100, 57-70(2000). (Pubitemid 30046295)
6. Veale D., T. Ashcroft, C. Marsh, G. J. Gibson & A. L. Harris: Epidermal growth factor receptors in non-small cell lung cancer. Br J Cancer 55, 513-516(1987) (Pubitemid 17098858)
7. Neal D. E., C. Marsh, M. K. Bennett, P. D. Abel, R. R. Hall, J. R. Sainsbury & A. L. Harris: Epidermal-growthfactor receptors in human bladder cancer: comparison of invasive and superficial tumours. Lancet 1, 366-368(1985) (Pubitemid 15163478)
8. Neal D. E., L. Sharples, K. Smith, J. Fennelly, R. R. Hall & A. L. Harris: The epidermal growth factor receptor and the prognosis of bladder cancer. Cancer 65, 1619-1625(1990) (Pubitemid 20106125)
9. Sainsbury J. R., J. R. Farndon, G. V. Sherbet & A. L. Harris: Epidermal-growth-factor receptors and oestrogen receptors in human breast cancer. Lancet 1, 364-366(1985) (Pubitemid 15163477)
10. Mirmohammadsadegh A., M. Hassan, A. Gustrau, R. Doroudi, N. Schmittner, S. Nambiar, A. Tannapfel, T. Ruzicka & U. R. Hengge: Constitutive expression of epidermal growth factor receptors on normal human melanocytes. J Invest Dermatol 125, 392-394(2005) (Pubitemid 41648177)
11. Grahn J. C. & R. R. Isseroff: Human melanocytes do not express EGF receptors. J Invest Dermatol 123, 244-246(2004) (Pubitemid 38833490)
12. Gordon-Thomson C., R. S. Mason & G. P. Moore: Regulation of epidermal growth factor receptor expression in human melanocytes. Exp Dermatol 10, 321-328(2001) (Pubitemid 32916281)
13. Fernandez A., E. Spitzer, R. Perez, F. D. Boehmer, K. Eckert, W. Zschiesche & R. Grosse: A new monoclonal antibody for detection of EGF-receptors in western blots and paraffin-embedded tissue sections. J Cell Biochem 49, 157-165(1992)
14. Mateo C., E. Moreno, K. Amour, J. Lombardero, W. Harris & R. Perez: Humanization of a mouse monoclonal antibody that blocks the epidermal growth factor receptor: recovery of antagonistic activity. Immunotechnology 3, 71-81(1997) (Pubitemid 27197395)
15. Suarez Pestana E., T. Tenev, S. Gross, B. Stoyanov, M. Ogata & F. D. Bohmer: The transmembrane protein tyrosine phosphatase RPTPsigma modulates signaling of the epidermal growth factor receptor in A431 cells. Oncogene 18, 4069-4079(1999) (Pubitemid 29363914)
16. Di Fiore P. P., J. H. Pierce, T. P. Fleming, R. Hazan, A. Ullrich, C. R. King, J. Schlessinger & S. A. Aaronson: Overexpression of the human EGF receptor confers an EGF-dependent transformed phenotype to NIH 3T3 cells. Cell 51, 1063-1070(1987)
17. Diaz A., E. Suarez, R. Blanco, T. Badia, D. Rivero, A. Lopez-Requena, A. Lopez & E. Montero: Functional expression of the human epidermal growth factor receptor in a melanoma cell line. Biotechnol Appl Biochem 48, 21-27(2007) (Pubitemid 47425171)
18. Barnes L. M., C. M. Bentley & A. J. Dickson: Stability of protein production from recombinant mammalian cells. Biotechnol Bioeng 81, 631-639(2003) (Pubitemid 36258516)
19. Pilla L., R. Valenti, A. Marrari, R. Patuzzo, M. Santinami, G. Parmiani & L. Rivoltini: Vaccination: role in metastatic melanoma. Expert Rev Anticancer Ther 6, 1305-1318(2006) (Pubitemid 44304698)
20. Cillo C., J. E. Dick, V. Ling & R. P. Hill: Generation of drug-resistant variants in metastatic B16 mouse melanoma cell lines. Cancer Res 47, 2604-2608(1987) (Pubitemid 17083148)
21. Gupta N., H. Wang, T. L. McLeod, C. C. Naus, S. Kyurkchiev, S. Advani, J. Yu, B. Perbal & R. R. Weichselbaum: Inhibition of glioma cell growth and tumorigenic potential by CCN3 (NOV). Mol Pathol 54, 293-299(2001) (Pubitemid 32928254)
22. Hofmann. U. B., R. Houben, E. B. Brocker & J. C. Becker: Role of matrix metalloproteinases in melanoma cell invasion. Biochimie 87, 307-314(2005) (Pubitemid 40387609)
23. MacKie R. M., R. Reid & B. Junor: Fatal melanoma transferred in a donated kidney 16 years after melanoma surgery. N Engl J Med 348, 567-568(2003) (Pubitemid 36159900)
24. Koebel C. M., W. Vermi, J. B. Swann, N. Zerafa, S. J. Rodig, L. J. Old, M. J. Smyth & R. D. Schreiber: Adaptive immunity maintains occult cancer in an equilibrium state. Nature 450, 903-907(2007). (Pubitemid 350231320)
25. Fidler I. J.: Biological behavior of malignant melanoma cells correlated to their survival in vivo. Cancer Res 35, 218-224(1975)
26. Lu Y., Y. Q. Wei, L. Tian, X. Zhao, L. Yang, B. Hu, B. Kan, Y. J. Wen, F. Liu, H. X. Deng, J. Li, Y. Q. Mao, S. Lei, M. J. Huang, F. Peng, Y. Jiang, H. Zhou, L. Q. Zhou & F. Luo: Immunogene therapy of tumors with vaccine based on xenogeneic epidermal growth factor receptor. J Immunol 170, 3162-3170(2003) (Pubitemid 36302193)
27. Dunn G. P., L. J. Old, R. & D. Schreiber: The three Es of cancer immunoediting. Annu Rev Immunol 22, 329-360(2004) (Pubitemid 38680426)
28. Zhou G., Z. Lu, J. D. McCadden, H. I. Levitsky & A. L. Marson: Reciprocal changes in tumor antigenicity and antigen-specific T cell function during tumor progression. J Exp Med 200, 1581-1592(2004) (Pubitemid 40094182)